Cytek Biosciences (CTKB) Preferred Dividend Payments (2020 - 2021)
Cytek Biosciences (CTKB) reported Preferred Dividend Payments of -$1.2 million for Q4 2021, down 104.35% on a YoY basis from $27.4 million in Q4 2020, and down 210.89% quarter-over-quarter from $1.1 million in Q3 2021.
Cytek Biosciences (CTKB) Preferred Dividend Payments (2020 - 2021) Analysis & Trends
Cytek Biosciences has reported Preferred Dividend Payments for 2 years, with the latest figure at -$1.2 million in Q4 2021.
- For the quarter ending Q4 2021, Preferred Dividend Payments fell 104.35% year-over-year to -$1.2 million; the trailing twelve-month figure through Dec 2022 stood at -$1.2 million (down 103.98% YoY), and the FY2021 full-year result was $3.0 million, down 81.47% from the prior year.
- Preferred Dividend Payments for Q4 2021 stood at -$1.2 million, down from $1.1 million in the prior quarter.
- The five-year high for Preferred Dividend Payments was $27.4 million in Q4 2020, with the low at -$6.2 million in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Cytek Biosciences | - | - | 21.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -1.19 Mn |
| Sep 30, 2021 | 1.07 Mn |
| Jun 30, 2021 | 2.67 Mn |
| Dec 31, 2020 | 27.37 Mn |
| Sep 30, 2020 | -5.09 Mn |
| Jun 30, 2020 | -6.21 Mn |